Management of Patients with Advanced Prostate Cancer:
Report of the Advanced Prostate Cancer Consensus Conference 2019

January 28, 2020 
Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some of these topics to supplement guidelines that are based on level 1 evidence.  
To read more, click here.